logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.

    Article - En anglais

    Objectives 

    To determine the anticipated participation in a prophylactic AIDS vaccine trial and to identify perceived benefits and barriers to enrollment of HIV-seronegative volunteers at risk of HIV infection in northern Thailand.

    Design 

    A cross-sectional survey.

    Methods 

    Subjects interviewed in a cross-sectional survey included female commercial sex workers (n=215), men attending sexually transmitted disease clinics (n=219), conscripts in the Royal Thai Army (n=1453), and men discharged from the army (n=293) who had returned to civilian life.

    Results 

    Awareness of vaccines (88-97%) and AIDS vaccine development efforts (62-77%) were common and viewed to be a complement to behavior change (74-94%). Approximately 25% of subjects would definitely join a trial if asked, and an additional 38% would accept an AIDS vaccine if they were convinced it would be safe and effective.

    Important barriers to participation included concerns with discrimination (16-45%), short- (37-60%) and long-term (30-55%) vaccine side-effects, fear of disability and death (36-58%), and beliefs that partners would refuse to have sex (24-49%) after immunization.

    The principal inducement to join a trial was health insurance (62%). Conclusion : Potential HIV vaccine trial participants have several fears of joining a vaccine study at this time.

    Information derived from Phase I/II trials is needed to address these concerns if enrollment in efficacy trials is to be successful in the near future.

    Mots-clés Pascal : SIDA, Virose, Infection, Volontaire, Homme, Vaccination, Prospective, Essai clinique, Immunoprophylaxie, Vaccin, Facteur risque, Thaïlande, Asie, Attitude, Immunopathologie, Immunodéficit, Prévention

    Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Volunteer, Human, Vaccination, Prospective, Clinical trial, Immunoprophylaxis, Vaccine, Risk factor, Thailand, Asia, Attitude, Immunopathology, Immune deficiency, Prevention

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 95-0543134

    Code Inist : 002B06D01. Création : 01/03/1996.